Effects of CYP2C19 and CYP2C9 genotypes on pharmacokinetic variability of valproic acid in Chinese epileptic patients: nonlinear mixed-effect modeling-Reference-Cited by-同舟云学术

Effects of CYP2C19 and CYP2C9 genotypes on pharmacokinetic variability of valproic acid in Chinese epileptic patients: nonlinear mixed-effect modeling

Published:2009-09-16 Issue:12 Volume:65 Page:1187-1193
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Jiang Dechun,Bai Xiangrong,Zhang Qingxia,Lu Wei,Wang Yuqin,Li Lin,Müller Markus

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-009-0712-x.pdf

Reference35 articles.

1. Georges B, Conil JM, Seguin T et al (2008) Cefepime in intensive care unit patients: validation of a population pharmacokinetic approach and influence of covariables. Int J Clin Pharmacol Ther 46:157–164

2. Chan PL, Weatherley B, McFadyen L (2008) A population pharmacokinetic meta-analysis of maraviroc in healthy volunteers and asymptomatic HIV-infected subjects. Br J Clin Pharmacol 65(Suppl 1):76–85

3. Punyawudho B, Ramsay RE, Macias FM et al (2008) Population pharmacokinetics of lamotrigine in elderly patients. J Clin Pharmacol 48:455–463

4. Ho PC, Abbott FS, Zanger UM et al (2003) Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomes. Pharmacogenomics J 3:335–342

5. Jankovic SM, Milovanovic JR (2007) Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients. Methods Find Exp Clin Pharmacol 29:673–679

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fixed parameters in the population pharmacokinetic modeling of valproic acid might not be suitable: external validation in Chinese adults with epilepsy or after neurosurgery;European Journal of Clinical Pharmacology;2024-08-29

2. Population Pharmacokinetics and Loading Dose Optimization of Intravenous Valproic Acid in Hospitalized Thai Patients;The Journal of Clinical Pharmacology;2024-07-29

3. Retrospective Analysis of Steady-State Sodium Valproate Plasma Concentrations in Chinese Patients With Bipolar Disorder: Impact of Demographic and Clinical Characteristics;Therapeutic Drug Monitoring;2024-04-19

4. Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study;Frontiers in Pharmacology;2023-10-06

5. Pharmacogenetic variants of CYP2C9 and CYP2C19 associated with adverse reactions induced by antiepileptic drugs used in Peru;Pharmacia;2023-08-15